Sonata has been studied in more than 3,700 patients throughout Europe, the United States and Canada, including elderly people ranging in age from 65 to 85. In clinical trials, Sonata demonstrated an excellent safety profile and was well tolerated. The most common side effects with Sonata are headache, weakness, drowsiness and dizziness. There are no drugs specifically contraindicated with Sonata. In both countries, Sonata will be available in 5 mg and 10 mg strengths in packages of seven and 14 capsules.
Insomnia affects approximately one-third of the general adult population.
Sleep deprivation can cause a variety of problems, including moodiness, loss of memory, inability to concentrate, and loss of energy. Insomnia also can be associated with more serious medical conditions, such as depression and anxiety, and is an important factor in automobile and industrial accidents. Any question regarding a medical diagnosis, treatment, referral, drug availability or pricing should be directed to either a licensed physician or to the product's manufacturer.